Hydralazine inhibits cysteamine dioxygenase to treat preeclampsia and senesce glioblastoma is a research paper published in The Medicine Forum (2024). On theSindex it has a DataRank of 0.104. It has been cited 1 time.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.104
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Science Foundation
Grant: 2204225
Cys-Tyr Cofactor in Iron and Copper Proteins
Wellcome Trust
Grant: unidentified
unidentified
National Institutes of Health
Grant: 1DP1DA051620-01
MAOI-inspired activity probes to translate epigenetics and genetics into drugs
National Institutes of Health
Grant: 1R37CA285434-01A1
Development and validation of an autologous mouse model for the study of immune interactions with glioblastoma
National Institutes of Health
Grant: 1R01DA036596-01A1
Regulation of Striatal Signaling by RGS Proteins
Fields of Study
Keywords